Literature DB >> 29396922

Simultaneous determination and qualitative analysis of six types of components in Naoxintong capsule by miniaturized matrix solid-phase dispersion extraction coupled with ultra high-performance liquid chromatography with photodiode array detection and quadrupole time-of-flight mass spectrometry.

Huilin Wang1, Yan Jiang1, Mingya Ding1,2, Jin Li2, Jia Hao1,2, Jun He1,2, Hui Wang1,2, Xiu-Mei Gao2, Yan-Xu Chang1,2.   

Abstract

A simple and effective sample preparation process based on miniaturized matrix solid-phase dispersion was developed for simultaneous determination of phenolic acids (gallic acid, chlorogenic acid, ferulic acid, 3,5-dicaffeoylqunic acid, 1,5-dicaffeoylqunic acid, rosmarinic acid, lithospermic acid, and salvianolic acid B), flavonoids (kaempferol-3-O-rutinoside, calycosin, and formononetin), lactones (ligustilide and butyllidephthalide), monoterpenoids (paeoniflorin), phenanthraquinones (cryptotanshinone), and furans (5-hydroxymethylfurfural) in Naoxintong capsule by ultra high-performance liquid chromatography. The optimized condition was that 25 mg Naoxintong powder was blended homogeneously with 100 mg Florisil PR for 4 min. One milliliter of methanol/water (75:25, v/v) acidified by 0.05% formic acid was selected to elute all components. It was found that the recoveries of the six types of components ranged from 61.36 to 96.94%. The proposed miniaturized matrix solid-phase dispersion coupled with ultra high-performance liquid chromatography was successfully applied to simultaneous determination of the six types of components in Naoxintong capsules. The results demonstrated that the proposed miniaturized matrix solid-phase dispersion coupled with ultra high-performance liquid chromatography could be used as an environmentally friendly tool for the extraction and determination of multiple bioactive components in natural products.
© 2018 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  miniaturized matrix solid-phase dispersion; quadrupole time-of-flight mass spectrometry; traditional Chinese medicine; ultra high performance liquid chromatography

Mesh:

Substances:

Year:  2018        PMID: 29396922     DOI: 10.1002/jssc.201701411

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  6 in total

Review 1.  Meta-Analysis of Naoxintong Capsule for Patients with Vascular Dementia.

Authors:  Li Li; Yawei Zheng; Jinjing Bao; Yandong Zhao; Qiuchi Zhang; Wenlei Li; Minghua Wu
Journal:  Evid Based Complement Alternat Med       Date:  2022-07-06       Impact factor: 2.650

Review 2.  Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery.

Authors:  Nicholas Ekow Thomford; Dimakatso Alice Senthebane; Arielle Rowe; Daniella Munro; Palesa Seele; Alfred Maroyi; Kevin Dzobo
Journal:  Int J Mol Sci       Date:  2018-05-25       Impact factor: 5.923

3.  Systems Pharmacology-Based Approach to Comparatively Study the Independent and Synergistic Mechanisms of Danhong Injection and Naoxintong Capsule in Ischemic Stroke Treatment.

Authors:  Junfeng Zhu; Xiaojiao Yi; Yiwen Zhang; Zongfu Pan; Like Zhong; Ping Huang
Journal:  Evid Based Complement Alternat Med       Date:  2019-02-04       Impact factor: 2.629

4.  A Rapid and Efficient Strategy for Quality Control of Clinopodii herba Encompassing Optimized Ultrasound-Assisted Extraction Coupled with Sensitive Variable Wavelength Detection.

Authors:  Yao Liu; Xiaojun Song; Xuebin Shen; Yuangen Xiong; Li Liu; Yuexi Yang; Sihui Nian; Limin Liu
Journal:  Molecules       Date:  2022-07-10       Impact factor: 4.927

5.  NaoXinTong Capsules inhibit the development of diabetic nephropathy in db/db mice.

Authors:  Shu Yang; Mengyang Liu; Yuanli Chen; Chuanrui Ma; Lipei Liu; Buchang Zhao; Yong Wang; Xiaoju Li; Yan Zhu; Xiumei Gao; Deling Kong; Yajun Duan; Jihong Han; Xiaoxiao Yang
Journal:  Sci Rep       Date:  2018-06-14       Impact factor: 4.379

6.  Protective effects of Naoxintong capsule alone and in combination with ticagrelor and atorvastatin in rats with Qi deficiency and blood stasis syndrome.

Authors:  Wei-Jian Zhang; Wei-Wei Su; Qing-Wei Lin; Yan He; Zeng-Hao Yan; Yong-Gang Wang; Pei-Bo Li; Hao Wu; Hong Liu; Hong-Liang Yao
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.